Article

Development and Characterization of a Potent Tumor Necrosis Factor-Alpha Blocking Agent

2019-02-13

Abstract excerpt

Tumor necrosis factor-α (TNFα), one of the major pro-inflammatory cytokines, plays a key role in an effective immune response. However, the chronic presence of TNFα can lead to several inflammatory disorders like rheumatoid arthritis, psoriasis, Crohn’s disease etc. Inhibition of TNFα by pharmacological inhibitors or antibodies has proven to be effective in palliative treatment to som...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c67bd20c-f260-5915-8a81-7fe2eb47e99b
DOI: 10.20944/preprints201902.0117.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and Characterization of a Potent Tumor Necrosis Factor-Alpha Blocking AgentDOI 10.20944/preprints201902.0117.v1Read

A New Venue of TNF TargetingSemantic proximity Read

Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseasesSemantic proximity Read

Prediction, scanning and designing of TNF-α inducing epitopes for human and mouseSemantic proximity Read

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeySemantic proximity Read

Apoptosis-Inducing TNF Superfamily Ligands for Cancer TherapySemantic proximity Read

Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamilySemantic proximity Read

TNF biology, pathogenic mechanisms and emerging therapeutic strategiesSemantic proximity Read

An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease.Semantic proximity Read

Construction and initial characterization of a mouse-human chimeric anti-TNF antibodySemantic proximity Read

Cell-type-restricted anti-cytokine therapy: TNF inhibition from one pathogenic source.Semantic proximity Read

Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonists.Semantic proximity Read

Targeting sTNF/TNFR1 Signaling as a New Therapeutic StrategySemantic proximity Read